Download PDF
Thromb Haemost 2018; 118(03): 502-513
DOI: 10.1055/s-0038-1627453
Cellular Haemostasis and Platelets
Schattauer GmbH Stuttgart

Suppressive Role of Tissue Factor Pathway Inhibitor-α in Platelet-Dependent Fibrin Formation under Flow Is Restricted to Low Procoagulant Strength

Stella Thomassen   *
,
Tom G. Mastenbroek   *
,
Frauke Swieringa
,
Kristien Winckers
,
Marion A.H. Feijge
,
Roy Schrijver
,
Judith M.E.M. Cosemans
,
Susan A. Maroney
,
Alan E. Mast
,
Tilman M. Hackeng
,
Johan W.M. Heemskerk
 Funding S.T., J.M.E.M.C., T.M.H. and J.W.M.H. were funded by the Center for Translational Molecular Medicine (INCOAG). T.G.M. and J.M.E.M.C. were funded by Dutch Heart Foundation (2015T79). J.M.E.M.C. was funded by the Netherlands Organization for Scientific Research (NWO Vidi 91716421). A.E.M. was funded by the National Heart, Lung, and Blood Institute grant HL068835. F.S. was funded by Alexander von Humboldt Foundation.
Further Information

Publication History

27 July 2017

21 December 2017

Publication Date:
16 February 2018 (online)

   Permissions and Reprints

Abstract

Tissue factor pathway inhibitor-alpha (TFPI-α) is a Kunitz-type serine protease inhibitor, which suppresses coagulation by inhibiting the tissue factor (TF)/factor VIIa complex as well as factor Xa. In static plasma-phospholipid systems, TFPI-α thus suppresses both factor Xa and thrombin generation. In this article, we used a microfluidics approach to investigate how TFPI-α regulates fibrin clot formation in platelet thrombi at low wall shear rate. We therefore hypothesized that the anticoagulant effect of TFPI-α in plasma is a function of the local procoagulant strength—defined as the magnitude of thrombin generation under flow, due to local activities of TF/factor VIIa and factor Xa. To test this hypothesis, we modulated local coagulation by microspot coating of flow channels with 0 to 100 pM TF/collagen, or by using blood from patients with haemophilia A or B. For blood or plasma from healthy subjects, blocking of TFPI-α enhanced fibrin formation, extending from a platelet thrombus, under flow only at <2 pM coated TF. This enhancement was paralleled by an increased thrombin generation. For mouse plasma, genetic deficiency in TFPI enhanced fibrin formation under flow also at 0 pM TF microspots. On the other hand, using blood from haemophilia A or B patients, TFPI-α antagonism markedly enhanced fibrin formation at microspots with up to 100 pM coated TF. We conclude that, under flow, TFPI-α is capable to antagonize fibrin formation in a manner dependent on and restricted by local TF/factor VIIa and factor Xa activities.

Keywords

fibrin clot formation - haemophilia - mouse - platelets - TFPI - thrombin generation

* Stella Thomassen and Tom G. Mastenbroek contributed equally.


Supplementary Material

 

  • References

  • 1 Salemink I, Franssen J, Willems GM, Hemker HC, Lindhout T. Inhibition of tissue factor-factor VIIa-catalyzed factor X activation by factor Xa-tissue factor pathway inhibitor. A rotating disc study on the effect of phospholipid membrane composition. J Biol Chem 1999; 274 (40) 28225-28232
    CrossrefPubMedGoogle Scholar
  • 2 Adams M. Tissue factor pathway inhibitor: new insights into an old inhibitor. Semin Thromb Hemost 2012; 38 (02) 129-134
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Broze Jr GJ, Girard TJ. Tissue factor pathway inhibitor: structure-function. Front Biosci (Landmark Ed) 2012; 17: 262-280
    CrossrefPubMedGoogle Scholar
  • 4 Winckers K, ten Cate H, Hackeng TM. The role of tissue factor pathway inhibitor in atherosclerosis and arterial thrombosis. Blood Rev 2013; 27 (03) 119-132
    CrossrefPubMedGoogle Scholar
  • 5 Maroney SA, Ellery PE, Wood JP, Ferrel JP, Martinez ND, Mast AE. Comparison of the inhibitory activities of human tissue factor pathway inhibitor (TFPI)α and TFPIβ. J Thromb Haemost 2013; 11 (05) 911-918
    CrossrefPubMedGoogle Scholar
  • 6 Burkhart JM, Vaudel M, Gambaryan S. , et al. The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways. Blood 2012; 120 (15) e73-e82
    CrossrefPubMedGoogle Scholar
  • 7 Maroney SA, Ferrel JP, Pan S. , et al. Temporal expression of alternatively spliced forms of tissue factor pathway inhibitor in mice. J Thromb Haemost 2009; 7 (07) 1106-1113
    CrossrefPubMedGoogle Scholar
  • 8 Girard TJ, Tuley E, Broze Jr GJ. TFPIβ is the GPI-anchored TFPI isoform on human endothelial cells and placental microsomes. Blood 2012; 119 (05) 1256-1262
    CrossrefPubMedGoogle Scholar
  • 9 Maroney SA, Ellery PE, Wood JP, Ferrel JP, Bonesho CE, Mast AE. Caveolae optimize tissue factor-Factor VIIa inhibitory activity of cell-surface-associated tissue factor pathway inhibitor. Biochem J 2012; 443 (01) 259-266
    CrossrefPubMedGoogle Scholar
  • 10 Ahnström J, Andersson HM, Hockey V. , et al. Identification of functionally important residues in TFPI Kunitz domain 3 required for the enhancement of its activity by protein S. Blood 2012; 120 (25) 5059-5062
    CrossrefPubMedGoogle Scholar
  • 11 Peraramelli S, Suylen DP, Rosing J, Hackeng TM. The Kunitz 1 and Kunitz 3 domains of tissue factor pathway inhibitor are required for efficient inhibition of factor Xa. Thromb Haemost 2012; 108 (02) 266-276
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Wood JP, Bunce MW, Maroney SA, Tracy PB, Camire RM, Mast AE. Tissue factor pathway inhibitor-alpha inhibits prothrombinase during the initiation of blood coagulation. Proc Natl Acad Sci U S A 2013; 110 (44) 17838-17843
    CrossrefPubMedGoogle Scholar
  • 13 Reglińska-Matveyev N, Andersson HM, Rezende SM. , et al. TFPI cofactor function of protein S: essential role of the protein S SHBG-like domain. Blood 2014; 123 (25) 3979-3987
    CrossrefPubMedGoogle Scholar
  • 14 Vincent LM, Tran S, Livaja R, Bensend TA, Milewicz DM, Dahlbäck B. Coagulation factor V(A2440G) causes east Texas bleeding disorder via TFPIα. J Clin Invest 2013; 123 (09) 3777-3787
    CrossrefPubMedGoogle Scholar
  • 15 Versteeg HH, Heemskerk JW, Levi M, Reitsma PH. New fundamentals in hemostasis. Physiol Rev 2013; 93 (01) 327-358
    CrossrefPubMedGoogle Scholar
  • 16 Siljander PR, Munnix IC, Smethurst PA. , et al. Platelet receptor interplay regulates collagen-induced thrombus formation in flowing human blood. Blood 2004; 103 (04) 1333-1341
    CrossrefPubMedGoogle Scholar
  • 17 van der Meijden PE, Munnix IC, Auger JM. , et al. Dual role of collagen in factor XII-dependent thrombus formation. Blood 2009; 114 (04) 881-890
    CrossrefPubMedGoogle Scholar
  • 18 Okorie UM, Denney WS, Chatterjee MS, Neeves KB, Diamond SL. Determination of surface tissue factor thresholds that trigger coagulation at venous and arterial shear rates: amplification of 100 fM circulating tissue factor requires flow. Blood 2008; 111 (07) 3507-3513
    CrossrefPubMedGoogle Scholar
  • 19 Berny MA, Munnix IC, Auger JM. , et al. Spatial distribution of factor Xa, thrombin, and fibrin(ogen) on thrombi at venous shear. PLoS One 2010; 5 (04) e10415
    Google Scholar
  • 20 Colace TV, Muthard RW, Diamond SL. Thrombus growth and embolism on tissue factor-bearing collagen surfaces under flow: role of thrombin with and without fibrin. Arterioscler Thromb Vasc Biol 2012; 32 (06) 1466-1476
    CrossrefPubMedGoogle Scholar
  • 21 Swieringa F, Baaten CC, Verdoold R. , et al. Platelet control of fibrin distribution and microelasticity in thrombus formation under flow. Arterioscler Thromb Vasc Biol 2016; 36 (04) 692-699
    CrossrefPubMedGoogle Scholar
  • 22 Cosemans JM, Angelillo-Scherrer A, Mattheij NJ, Heemskerk JW. The effects of arterial flow on platelet activation, thrombus growth, and stabilization. Cardiovasc Res 2013; 99 (02) 342-352
    CrossrefPubMedGoogle Scholar
  • 23 Mattheij NJ, Swieringa F, Mastenbroek TG. , et al. Coated platelets function in platelet-dependent fibrin formation via integrin αIIbβ3 and transglutaminase factor XIII. Haematologica 2016; 101 (04) 427-436
    CrossrefPubMedGoogle Scholar
  • 24 Swieringa F, Kuijpers MJ, Lamers MM, van der Meijden PE, Heemskerk JW. Rate-limiting roles of the tenase complex of factors VIII and IX in platelet procoagulant activity and formation of platelet-fibrin thrombi under flow. Haematologica 2015; 100 (06) 748-756
    CrossrefPubMedGoogle Scholar
  • 25 Pedersen B, Holscher T, Sato Y, Pawlinski R, Mackman N. A balance between tissue factor and tissue factor pathway inhibitor is required for embryonic development and hemostasis in adult mice. Blood 2005; 105 (07) 2777-2782
    CrossrefPubMedGoogle Scholar
  • 26 Ellery PE, Maroney SA, Cooley BC. , et al. A balance between TFPI and thrombin-mediated platelet activation is required for murine embryonic development. Blood 2015; 125 (26) 4078-4084
    CrossrefPubMedGoogle Scholar
  • 27 Parunov LA, Fadeeva OA, Balandina AN. , et al. Improvement of spatial fibrin formation by the anti-TFPI aptamer BAX499: changing clot size by targeting extrinsic pathway initiation. J Thromb Haemost 2011; 9 (09) 1825-1834
    CrossrefPubMedGoogle Scholar
  • 28 Schols SE, Lancé MD, Feijge MA. , et al. Impaired thrombin generation and fibrin clot formation in patients with dilutional coagulopathy during major surgery. Thromb Haemost 2010; 103 (02) 318-328
    Article in Thieme ConnectPubMedGoogle Scholar
  • 29 Van Kruchten R, Cosemans JM, Heemskerk JW. Measurement of whole blood thrombus formation using parallel-plate flow chambers - a practical guide. Platelets 2012; 23 (03) 229-242
    CrossrefPubMedGoogle Scholar
  • 30 Munnix IC, Kuijpers MJ, Auger J. , et al. Segregation of platelet aggregatory and procoagulant microdomains in thrombus formation: regulation by transient integrin activation. Arterioscler Thromb Vasc Biol 2007; 27 (11) 2484-2490
    CrossrefPubMedGoogle Scholar
  • 31 Cosemans JM, Schols SE, Stefanini L. , et al. Key role of glycoprotein Ib/V/IX and von Willebrand factor in platelet activation-dependent fibrin formation at low shear flow. Blood 2011; 117 (02) 651-660
    CrossrefPubMedGoogle Scholar
  • 32 Westein E, van der Meer AD, Kuijpers MJ, Frimat JP, van den Berg A, Heemskerk JW. Atherosclerotic geometries exacerbate pathological thrombus formation poststenosis in a von Willebrand factor-dependent manner. Proc Natl Acad Sci U S A 2013; 110 (04) 1357-1362
    CrossrefPubMedGoogle Scholar
  • 33 van der Meijden PE, Feijge MA, Swieringa F. , et al. Key role of integrin α(IIb)β (3) signaling to Syk kinase in tissue factor-induced thrombin generation. Cell Mol Life Sci 2012; 69 (20) 3481-3492
    CrossrefPubMedGoogle Scholar
  • 34 Winckers K, Thomassen S, Ten Cate H, Hackeng TM. Platelet full length TFPI-α in healthy volunteers is not affected by sex or hormonal use. PLoS One 2017; 12 (02) e0168273
    CrossrefPubMedGoogle Scholar
  • 35 de Witt SM, Swieringa F, Cavill R. , et al. Identification of platelet function defects by multi-parameter assessment of thrombus formation. Nat Commun 2014; 5: 4257
    CrossrefPubMedGoogle Scholar
  • 36 Chan JC, Carmeliet P, Moons L. , et al. Factor VII deficiency rescues the intrauterine lethality in mice associated with a tissue factor pathway inhibitor deficit. J Clin Invest 1999; 103 (04) 475-482
    CrossrefPubMedGoogle Scholar
  • 37 Repke D, Gemmell CH, Guha A, Turitto VT, Broze Jr GJ, Nemerson Y. Hemophilia as a defect of the tissue factor pathway of blood coagulation: effect of factors VIII and IX on factor X activation in a continuous-flow reactor. Proc Natl Acad Sci U S A 1990; 87 (19) 7623-7627
    CrossrefPubMedGoogle Scholar
  • 38 Nordfang O, Valentin S, Beck TC, Hedner U. Inhibition of extrinsic pathway inhibitor shortens the coagulation time of normal plasma and of hemophilia plasma. Thromb Haemost 1991; 66 (04) 464-467
    Article in Thieme ConnectPubMedGoogle Scholar
  • 39 Welsch DJ, Novotny WF, Wun TC. Effect of lipoprotein-associated coagulation inhibitor (LACI) on thromboplastin-induced coagulation of normal and hemophiliac plasmas. Thromb Res 1991; 64 (02) 213-222
    CrossrefPubMedGoogle Scholar
  • 40 Peraramelli S, Thomassen S, Heinzmann A. , et al. Direct inhibition of factor VIIa by TFPI and TFPI constructs. J Thromb Haemost 2013; 11 (04) 704-714
    CrossrefPubMedGoogle Scholar
  • 41 Wood JP, Ellery PE, Maroney SA, Mast AE. Protein S is a cofactor for platelet and endothelial tissue factor pathway inhibitor-α but not for cell surface-associated tissue factor pathway inhibitor. Arterioscler Thromb Vasc Biol 2014; 34 (01) 169-176
    CrossrefPubMedGoogle Scholar
  • 42 van 't Veer C, Hackeng TM, Delahaye C, Sixma JJ, Bouma BN. Activated factor X and thrombin formation triggered by tissue factor on endothelial cell matrix in a flow model: effect of the tissue factor pathway inhibitor. Blood 1994; 84 (04) 1132-1142
    PubMedGoogle Scholar
  • 43 Hackeng TM, Seré KM, Tans G, Rosing J. Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor. Proc Natl Acad Sci U S A 2006; 103 (09) 3106-3111
    CrossrefPubMedGoogle Scholar
  • 44 Shibeko AM, Lobanova ES, Panteleev MA, Ataullakhanov FI. Blood flow controls coagulation onset via the positive feedback of factor VII activation by factor Xa. BMC Syst Biol 2010; 4: 5
    CrossrefPubMedGoogle Scholar
  • 45 Gorczyca ME, Nair SC, Jilma B. , et al. Inhibition of tissue factor pathway inhibitor by the aptamer BAX499 improves clotting of hemophilic blood and plasma. J Thromb Haemost 2012; 10 (08) 1581-1590
    CrossrefPubMedGoogle Scholar
  • 46 Erhardtsen E, Ezban M, Madsen MT. , et al. Blocking of tissue factor pathway inhibitor (TFPI) shortens the bleeding time in rabbits with antibody induced haemophilia A. Blood Coagul Fibrinolysis 1995; 6 (05) 388-394
    CrossrefPubMedGoogle Scholar
  • 47 Hilden I, Lauritzen B, Sørensen BB. , et al. Hemostatic effect of a monoclonal antibody mAb 2021 blocking the interaction between FXa and TFPI in a rabbit hemophilia model. Blood 2012; 119 (24) 5871-5878
    CrossrefPubMedGoogle Scholar
  • 48 Badellino KO, Walsh PN. Protease nexin II interactions with coagulation factor XIa are contained within the Kunitz protease inhibitor domain of protease nexin II and the factor XIa catalytic domain. Biochemistry 2000; 39 (16) 4769-4777
    CrossrefPubMedGoogle Scholar